title: Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?
abstract: Critical illness trials involving genetic data collection are increasingly commonplace and pose challenges not encountered in less acute settings, related in part to the precipitous, severe and incapacitating nature of the diseases involved. We performed a systematic literature review to understand the nature of such studies conducted to date, and to consider, from an ethical perspective, potential barriers to future investigations. We identified 79 trials enrolling 24 499 subjects. Median (interquartile range) number of participants per study was 263 (116.75-430.75). Of these individuals, 16 269 (66.4%) were Caucasian, 1327 (5.4%) were African American, 1707 (7.0%) were Asian Pacific Islanders and 139 (0.6%) were Latino. For 5020 participants (20.5%), ethnicity was not reported. Forty-eight studies (60.8%) recruited subjects from single centers and all studies examined a relatively small number of genetic markers. Technological advances have rendered it feasible to conduct clinical studies using high-density genome-wide scanning. It will be necessary for future critical illness trials using these approaches to be of greater scope and complexity than those so far reported. Empirical research into issues related to greater ethnic inclusivity, accuracy of substituted judgment and specimen stewardship may be essential for enabling the conduct of such trials.
authors.affiliation: Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA. freemanb@wustl.edu
authors.forename: B D
authors.initials: BD
authors.lastname: Freeman
authors.forename: C R
authors.initials: CR
authors.lastname: Kennedy
authors.forename: H L
authors.initials: HL
authors.lastname: Frankel
authors.forename: B
authors.initials: B
authors.lastname: Clarridge
authors.forename: D
authors.initials: D
authors.lastname: Bolcic-Jankovic
authors.forename: E
authors.initials: E
authors.lastname: Iverson
authors.forename: E
authors.initials: E
authors.lastname: Shehane
authors.forename: A
authors.initials: A
authors.lastname: Celious
authors.forename: B A
authors.initials: BA
authors.lastname: Zehnbauer
authors.forename: T G
authors.initials: TG
authors.lastname: Buchman
mesh_terms: D000328:Adult; D001741:Black or African American; D001213:Asian; D035843:Biomedical Research / Q000941:ethics*; D016638:Critical Illness; D014644:Genetic Variation; D006630:Hispanic or Latino; D006801:Humans; D007258:Informed Consent / Q000941:ethics; D009102:Multiple Organ Failure / Q000208:ethnology / Q000235:genetics*; D018579:Patient Selection / Q000941:ethics*; D016032:Randomized Controlled Trials as Topic / Q000941:ethics*; D018805:Sepsis / Q000208:ethnology / Q000235:genetics*; D012772:Shock, Septic / Q000208:ethnology / Q000235:genetics*; D044465:White People